YOLFTbeta
RHYTHM Biosciences Ltd

RHYTHM Biosciences Ltd

RHY · AU · Healthcare / Diagnostics & Research

0.066AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.066
Open0.067
Day Range0.066 – 0.067
52-Week Range0.075 – 0.28
Volume102.03K
Market Cap28.31M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.02
Dividend Yield0.00%
Beta0.43
50-Day Avg0.0853
200-Day Avg0.1346

About

Rhythm Biosciences Limited, a medical diagnostics company, develops and commercialises medical diagnostic tests for cancer detection in Australia and the United States. The company offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. Rhythm Biosciences Limited was incorporated in 2017 and is headquartered in Parkville, Australia.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEODr. David Atkins M.B.A., Ph.D.
  • Employees0
  • HeadquartersBio21 Institute, Parkville, VIC, Australia, 3010, Australia
  • Websitehttps://rhythmbio.com

Leadership

  • Dr. David Atkins M.B.A., Ph.D.CEO & Director · b. 1965
  • Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSPCompany secretary · b. 1964

Financials

Income Statement

Currency: AUD2017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue064.48K1.03M100.00K1.11M2.43M3.10M1.69M3.19M85.34K
Growth (%)--+1494.29%-90.27%+1009.00%+118.85%+27.56%-45.41%+88.87%-97.33%
Cost of Revenue031.54K65.36K141.29K146.65K101.48K189.38K3.05M224.89K4.48M
Gross Profit0-31.54K962.25K-41.29K961.86K-101.48K2.91M-1.36M2.97M-4.40M
Gross Margin--48.91%93.60%-41.29%86.73%-4.18%93.86%-80.30%92.95%-5151.30%
Operating Expense72.13K1.57M4.68M3.88M7.44M8.62M14.45M5.35M6.50M3.06M
Operating Income-72.13K-1.60M-3.71M-3.92M-6.48M-8.72M-11.54M-6.71M-3.53M-7.46M
Operating Margin--2476.74%-361.38%-3920.00%-584.13%-359.17%-372.80%-396.86%-110.68%-8739.15%
EBITDA733.40K-1.60M-3.51M-3.87M-6.46M-11.10M-11.11M-8.35M-3.53M-7.27M
EBITDA Margin--2476.74%-341.31%-3874.00%-582.96%-457.52%-358.82%-493.79%-110.68%-8517.35%
Net Income-72.13K-1.75M-2.55M-4.02M-6.61M-8.79M-8.22M-6.86M-3.83M-5.93M
Net Income Margin--2718.67%-247.67%-4023.00%-596.21%-362.34%-265.44%-405.74%-119.97%-6948.85%
R&D299.52K359.11K980.28K1.94M4.55M5.16M3.65M2.35M1.38M1.04M
R&D as % of Total Revenue-556.93%95.36%1939.00%410.73%212.57%117.83%138.82%43.36%1218.59%
Interest Expense0007.80K39624.96K-3.14K66.72K74.80K
Interest Expense % of Total Revenue-0.00%0.00%7.80%0.04%1.03%-0.19%2.09%87.65%

Balance Sheet

Currency: AUD2017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets1.55M8.45M6.23M2.65M3.07M8.44M7.70M1.52M2.83M4.78M
Total Liabilities126.48K147.38K379.71K802.85K1.36M1.07M1.82M651.54K2.17M1.14M
Total Equity1.42M8.30M5.85M1.84M1.71M7.37M5.87M867.17K659.89K3.64M
Cash1.49M7.78M4.73M1.80M2.23M7.55M4.12M709.50K1.40M3.36M
Total Debt---42.44K-170.14K84.61K163.82K1.11M247.98K
Net Debt-1.49M-7.78M-4.73M-1.76M-2.23M-7.38M-4.04M-545.67K-289.94K-3.11M

Cash Flow

Currency: AUD2017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-13-1.65M-2.94M-2.74M-5.40M-6.21M-6.96M-6.14M-2.92M-5.23M
Investing Cash Flow-355.76K-355.76K-110.26K-45.53K-68.27K-27.01K-99.12K-82.28K-582.96K-22.75K
Financing Cash Flow1.50M8.29M-142.22K-142.22K5.90M11.85M3.63M2.80M4.19M7.22M
Capital Expenditure10.76K310.76K110.26K45.53K68.27K27.01K99.12K82.28K23.21K25.79K
Free Cash Flow-13-1.96M-3.05M-2.79M-5.47M-6.24M-7.06M-6.22M-2.94M-5.26M
FCF to OCF100.00%118.82%103.75%101.66%101.26%100.43%101.42%101.34%100.79%100.49%

Earnings

Report DateFeb 27, 2018Aug 31, 2018Feb 26, 2019Aug 29, 2019Feb 26, 2020Aug 31, 2020Feb 24, 2021Aug 31, 2021Feb 24, 2022Aug 29, 2022Feb 23, 2023Feb 20, 2025Aug 29, 2025Feb 18, 2026
EPS Estimate0.000.000.000.000.000.000.00----0.000.000.00
EPS Actual-0.01-0.01-0.01-0.01-0.02-0.02-0.01-0.03-0.02-0.02-0.020.00-0.02-0.01
Surprise--------------
Timing--------After-hoursAfter-hoursAfter-hours---

Key Statistics & Ratios

Market Cap28.31M
Enterprise Value25.82M
Trailing P/E0.00
Forward P/E0.00
Price / Sales16.26
Price / Book7.98
EPS-0.02
Book Value0.01
Revenue (TTM)1.74M
Gross Profit (TTM)1.33M
EBITDA-5.67M
Profit Margin0.00%
Operating Margin-3067.49%
Return on Equity-276.00%
Return on Assets-96.20%
Shares Outstanding353.87M
Shares Float255.24M
Beta0.43
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%